Bleomycin - a clinical evaluation of the agent on its own or in combination with mitomycin C

This is a report of results in 93 patients treated with bleomycin (supplied by Bristol Laboratories for trial purposes), an antitumour antibiotic with no haemopoietic toxicity.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	South African medical journal 1972-12, Vol.46 (49), p.1921-1926
1. Verfasser:	van Dyk, J.J., Falkson, G. & Falkson, H.C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotic Antibiotics, Antineoplastic - therapeutic use Bleomycin Bleomycin - administration & dosage Bleomycin - adverse effects Bleomycin - therapeutic use Combination therapy Drug Eruptions - etiology Female Hodgkin Disease - drug therapy Humans Injections, Intravenous Lymphoma, Large B-Cell, Diffuse - drug therapy Male Microbiology Mitomycin C Mitomycins - administration & dosage Mitomycins - therapeutic use Neoplasms - drug therapy Pharmacology Pigmentation Disorders - chemically induced Rectal Neoplasms - drug therapy Remission, Spontaneous
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This is a report of results in 93 patients treated with bleomycin (supplied by Bristol Laboratories for trial purposes), an antitumour antibiotic with no haemopoietic toxicity.
ISSN:	0256-9574 2078-5135